Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bogus diabetes test strips

This article was originally published in The Gray Sheet

Executive Summary

Counterfeit test strips distributed in the U.S. by Medical Plastic Devices of Quebec, Canada, and Champion Sales of Brooklyn, N.Y., for use with various models of Johnson & Johnson/LifeScan One Touch blood glucose monitors could give incorrect readings, leading to the administration of too much or too little insulin and potential complications, according to an Oct. 13 FDA release. Patients in possession of One Touch Basic/Profile (lot #272894A, 2619932 or 2606340) or One Touch Ultra (lot #2691191) strips should discontinue use and contact their physician, FDA says. The agency is investigating the matter. Abbott and Roche also have been targeted by counterfeiters in recent years (1"The Gray Sheet" March 8, 2004, p. 15)...

You may also be interested in...



Abbott Blood Glucose Test Strips Target Of Alternate Source Market

FDA is investigating sales of counterfeit packages of Precision QID blood glucose test strips manufactured by Abbott Labs

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.

Metsera Launches As New Obesity Contender Flush With $290m

Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture. 

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024076

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel